Mochida Pharmaceutical Co., Ltd. (TYO:4534)
Japan
· Delayed Price · Currency is JPY 2,975.00
+37.00 (1.26%)
May 21, 2025, 3:30 PM JST
Mochida Pharmaceutical Revenue
In the fiscal year ending March 31, 2025, Mochida Pharmaceutical had annual revenue of 105.16B JPY with 2.21% growth. Mochida Pharmaceutical had revenue of 24.43B in the quarter ending March 31, 2025, a decrease of -0.97%.
Revenue
105.16B
Revenue Growth
+2.21%
P/S Ratio
1.00
Revenue / Employee
69.09M
Employees
1,522
Market Cap
105.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 105.16B | 2.27B | 2.21% |
| Mar 31, 2024 | 102.89B | -376.00M | -0.36% |
| Mar 31, 2023 | 103.26B | -6.92B | -6.28% |
| Mar 31, 2022 | 110.18B | 7.18B | 6.98% |
| Mar 31, 2021 | 103.00B | 1.20B | 1.17% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |